Should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.
Renal or hepatic impairment: No dose adjustment required.
Use in Pregnancy: There are no adequate and well-controlled studies in pregnant woman. Linagliptin tablets should be used during pregnancy only if the potential benefit of mother justifies the potential risk of the fetus.
Use in Lactation: Caution should be exercised when Linagliptin is administered to a nursing woman.
Use in Children: Safety and effectiveness of Linagliptin in patients below the age of 18 have not been established.